InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: XenaLives post# 204590

Monday, 08/05/2019 12:59:24 PM

Monday, August 05, 2019 12:59:24 PM

Post# of 463654
Didn't say that they did. I said that the previous trials were P1 which are much cheaper than P2/3, so it makes sense that minimal dilution would be necessary. Now that we're getting into the more expensive trials, we are seeing $250M shelf offerings.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News